Skip to main content

Table 1 Patent expiry of blockbuster drug in 2016

From: Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry

Drug (trade name)

Date of expiration/country

Company

Application area

Alimta®

2016/US

Eli Lilly

Cancer

Benicar®

2016/US

Daiichi Sankyo

Blood pressure medication

Benicar HTC®

2016/US

Daiichi Sankyo

Blood pressure medication

Crestor®

2016/US

Astra Zeneca

Lowering LDL cholesterol

Cubicin®

2016/US

Merck

Bacterial infection

Zetia®

2016/US

Merck

Lowering LDL cholesterol

Baraclude®

2016/JP

Bristol–Myers Squibb

Antiviral medication (hepatitis B virus)

Glivec®

2016/EU

Novartis

Myeloid leukemia

Vfend®

2016/EU

Pfizer

Antifungal medication

  1. Patent expirations dates are subject to change due to patent litigation, additional patents and other market exclusivities. Patent expirations do not imply immediate generic availability